A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular ...

In this MedPage Today video segment, Linda Stein Gold, MD, director of dermatology clinical research at the Henry Ford Health ...

A potential for cumulative life course impairment is not completely considered in clinical practice, driving the ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the underlying issue involves immune response and skin-cell overproduction, there’s ...

PsO is a systemic inflammatory disease that presents not only as scaly skin lesions, erythema, and itching but also affects ...

Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

A tattoo can trigger a psoriasis flare. These tips will help you reduce that risk and keep your tattoos looking good.

Affecting two to three percent of the global population, psoriasis should be viewed for what it is: a serious systemic ...

Psoriasis involves immune dysregulation and a lipid-driven mechanism in which FABP5 induces ferroptosis. Blocking FABP5 eases ...

Ixekizumab was more effective for the treatment of mild to moderate psoriasis vs severe psoriasis at most time points through 52 weeks.

Eczema and psoriasis often worsen in winter due to cold air, low humidity, indoor heating and reduced sunlight.